Skip to main content

Research Repository

Advanced Search

Blood Serum Cytokines in Patients with Subacute Spinal Cord Injury: A Pilot Study to Search for Biomarkers of Injury Severity

Ogurcov, Sergei; Shulman, Iliya; Garanina, Ekaterina; Sabirov, Davran; Baichurina, Irina; Kuznetcov, Maxim; Masgutova, Galina; Kostennikov, Alexander; Rizvanov, Albert; James, Victoria; Mukhamedshina, Yana

Blood Serum Cytokines in Patients with Subacute Spinal Cord Injury: A Pilot Study to Search for Biomarkers of Injury Severity Thumbnail


Authors

Sergei Ogurcov

Iliya Shulman

Ekaterina Garanina

Davran Sabirov

Irina Baichurina

Maxim Kuznetcov

Galina Masgutova

Alexander Kostennikov

Albert Rizvanov

Yana Mukhamedshina



Abstract

Background: Despite considerable interest in the search for a spinal cord injury (SCI) therapy, there is a critical need to develop a panel of diagnostic biomarkers to determine injury severity. In this regard, there is a requirement for continuing research into the fundamental processes of neuroinflammatory and autoimmune reactions in SCI, identifying changes in the expression of cytokines.

Methods: In this pilot study, an extended multiplex analysis of the cytokine profiles in the serum of patients at 2 weeks post-SCI (n = 28) was carried out, together with an additional assessment of neuron-specific enolase (NSE) and vascular endothelial growth factor (VEGF) levels by enzyme-linked immunosorbent assay. A total of 16 uninjured subjects were enrolled as controls.

Results: The data obtained showed a large elevation of IFNγ (>52 fold), CCL27 (>13 fold), and CCL26 (>8 fold) 2 weeks after SCI. The levels of cytokines CXCL5, CCL11, CXCL11, IL10, TNFα, and MIF were different between patients with baseline American Spinal Injury Association Impairment Scale (AIS) grades of A or B, whilst IL2 (>2 fold) and MIP-3a (>6 fold) were significantly expressed in the cervical and thoracic regions. There was a trend towards increasing levels of NSE. However, the difference in NSE was lost when the patient set was segregated based on AIS group.

Conclusions: Our pilot research demonstrates that serum concentrations of cytokines can be used as an affordable and rapid detection tool to accurately stratify SCI severity in patients.

Citation

Ogurcov, S., Shulman, I., Garanina, E., Sabirov, D., Baichurina, I., Kuznetcov, M., Masgutova, G., Kostennikov, A., Rizvanov, A., James, V., & Mukhamedshina, Y. (2021). Blood Serum Cytokines in Patients with Subacute Spinal Cord Injury: A Pilot Study to Search for Biomarkers of Injury Severity. Brain Sciences, 11(3), Article 322. https://doi.org/10.3390/brainsci11030322

Journal Article Type Article
Acceptance Date Feb 26, 2021
Online Publication Date Mar 4, 2021
Publication Date Mar 4, 2021
Deposit Date Mar 12, 2021
Publicly Available Date Mar 12, 2021
Journal Brain Sciences
Publisher MDPI
Peer Reviewed Peer Reviewed
Volume 11
Issue 3
Article Number 322
DOI https://doi.org/10.3390/brainsci11030322
Keywords Traumatic spinal cord injury, Cytokine profile, Inflammation, Blood serum, Clinical trial.
Public URL https://nottingham-repository.worktribe.com/output/5376951
Publisher URL https://www.mdpi.com/2076-3425/11/3/322

Files





You might also like



Downloadable Citations